NI.O.27 - MuSK MG patients showed a positive response to amifampridine phosphate in a randomized, placebo-controlled, crossover study.

MLA

Mantegazza, R., et al. “NI.O.27 - MuSK MG Patients Showed a Positive Response to Amifampridine Phosphate in a Randomized, Placebo-Controlled, Crossover Study.” Neuromuscular Disorders, vol. 27, Oct. 2017, p. S249. EBSCOhost, https://doi.org/10.1016/j.nmd.2017.06.553.

APA

Mantegazza, R., Pasanisi, B., Antozzi, C., Maggi, L., Andreetta, F., Simoncini, O., & Bonanno, S. (2017). NI.O.27 - MuSK MG patients showed a positive response to amifampridine phosphate in a randomized, placebo-controlled, crossover study. Neuromuscular Disorders, 27, S249. https://doi.org/10.1016/j.nmd.2017.06.553

Chicago

Mantegazza, R., B. Pasanisi, C. Antozzi, L. Maggi, F. Andreetta, O. Simoncini, and S. Bonanno. 2017. “NI.O.27 - MuSK MG Patients Showed a Positive Response to Amifampridine Phosphate in a Randomized, Placebo-Controlled, Crossover Study.” Neuromuscular Disorders 27 (October): S249. doi:10.1016/j.nmd.2017.06.553.